Dear List mates,

Maybe You could be interested in my last publication.

If you would like to have, for free, the PDF of the article, go, please, to the reported link.

Article title: Scrimali T (2023). Cannabidiol, NegEnt and Panic Disorder
Doi: 10.20944/preprints202302.0464.v1
Website: https://www.preprints.org/manuscript/202302.0464/v1
Topic: Cannabis, Cannabinoids and Its Derivatives, Cognitive Therapy, Panic Disorder

Sincerely:
Prof. Tullio Scrimali, MD and PhD
ORCID Code: orcid.org/0000-0002-1880-1856
Psychiatrist, Psychotherapist, Clinical Neuroscientist and Medical Cannabis Scientist (www.tullioscrimali.it)
Professor of Clinical Psychology and Rehabilitation, Medical School, Department of Medical, Chirurgical Sciences and Advanced Technologies
Visiting Professor, Department of Psychology, Asia University, Taichung, Taiwan
Visiting Professor at the Boston University, School of Social Work
Founding Fellow and Cognitive Therapy Certified Trainer Consultant of the Academy of Cognitive Therapy (ACT)
Member of the International Association for Cognitive Psychotherapy (IACP)
Member of the European Association of Behavioural and Cognitive Therapy (EABCT)
Founder and Director of ALETEIA International, European School of Cognitive Therapy
Founder and Director of ALETEIA Center for Mental Health
Founder and Director of ALETEIA Lab for Applied Neuroscience
Founder and Director of Cannabis Medica ALETEIA
Founder and Director of Herbal Neurocare
Via Gramsci n.3 (95021) Acicastello (Catania) - ITALY – Telephone: +39095492945 – Fax: +390957127749 – E-mail: tullio.scrimali@unict.it (institutional) and tscrimact@gmail.com (private)
Author of the following books, in English:
Cognitive Therapy Towards a New Millennium (Edited with Grimaldi, L.). Kluver, New York, 2001
Entropy of Mind and Negative Entropy. A cognitive and complex approach to schizophrenia and its therapy. Karnac, London, 2008
Neuroscience-Based Cognitive Therapy. New methods for assessment, treatment and self-regulation. Wiley, Chichester, 2012